Barinthus Biotherapeutics plc. Liquidation Value
BRNS
Other
Cash & Equivalents
$70.46M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $70.46M
Total Obligations: -$21.30M
$49.16M
Per share: $1.20
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $70.46M
AR: $0
Total Obligations: -$21.30M
$49.16M
Per share: $1.20
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $70.46M
AR: $0
Inventory: $0
Total Obligations: -$21.30M
$49.16M
Per share: $1.20
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $49.16M | $1.20 |
| Liquid Liquidation Value | $49.16M | $1.20 |
| Operating Liquidation Value | $49.16M | $1.20 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $70.46M |
| Accounts Receivable | $14.97M |
| Inventory | N/A |
| Current Liabilities | $10.02M |
| Long-term Debt | N/A |
| Op. Lease Liability | $11.28M |
| Finance Lease | N/A |
| Shares Outstanding | 40.8M |
Explore all 169 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $70.46M | N/A | N/A | $350,000 | $10.02M | N/A | $11.28M | N/A |
| 2025-09-30 | $74.27M | N/A | N/A | $698,000 | $10.80M | N/A | $11.57M | N/A |
| 2025-06-30 | $86.26M | N/A | N/A | $1.80M | $12.72M | N/A | $11.99M | N/A |
| 2025-03-31 | $99.12M | N/A | N/A | $1.36M | $11.98M | N/A | $11.92M | N/A |
| 2024-12-31 | $110.66M | N/A | N/A | $2.47M | $15.66M | N/A | $12.01M | N/A |
| 2024-09-30 | $106.10M | $14.97M | N/A | $3.08M | $15.07M | N/A | $12.67M | N/A |
| 2024-06-30 | $117.77M | N/A | N/A | $2.56M | $15.59M | N/A | $12.57M | N/A |
| 2024-03-31 | $129.97M | N/A | N/A | $1.16M | $12.84M | N/A | $12.81M | N/A |
▼ Community Notes